526 related articles for article (PubMed ID: 31093990)
1. UBR5 is a novel E3 ubiquitin ligase involved in skeletal muscle hypertrophy and recovery from atrophy.
Seaborne RA; Hughes DC; Turner DC; Owens DJ; Baehr LM; Gorski P; Semenova EA; Borisov OV; Larin AK; Popov DV; Generozov EV; Sutherland H; Ahmetov II; Jarvis JC; Bodine SC; Sharples AP
J Physiol; 2019 Jul; 597(14):3727-3749. PubMed ID: 31093990
[TBL] [Abstract][Full Text] [Related]
2. Differential gene expression of muscle-specific ubiquitin ligase MAFbx/Atrogin-1 and MuRF1 in response to immobilization-induced atrophy of slow-twitch and fast-twitch muscles.
Okamoto T; Torii S; Machida S
J Physiol Sci; 2011 Nov; 61(6):537-46. PubMed ID: 21901639
[TBL] [Abstract][Full Text] [Related]
3. Differences in the Role of HDACs 4 and 5 in the Modulation of Processes Regulating MAFbx and MuRF1 Expression during Muscle Unloading.
Mochalova EP; Belova SP; Kostrominova TY; Shenkman BS; Nemirovskaya TL
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32646070
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of the E3 ubiquitin ligase UBR5 and its role in skeletal muscle anabolism.
Hughes DC; Turner DC; Baehr LM; Seaborne RA; Viggars M; Jarvis JC; Gorski PP; Stewart CE; Owens DJ; Bodine SC; Sharples AP
Am J Physiol Cell Physiol; 2021 Jan; 320(1):C45-C56. PubMed ID: 33052072
[TBL] [Abstract][Full Text] [Related]
5. UBE2D2 is not involved in MuRF1-dependent muscle wasting during hindlimb suspension.
Polge C; Koulmann N; Claustre A; Jarzaguet M; Serrurier B; Combaret L; Béchet D; Bigard X; Attaix D; Taillandier D
Int J Biochem Cell Biol; 2016 Oct; 79():488-493. PubMed ID: 27378730
[TBL] [Abstract][Full Text] [Related]
6. P38α-MAPK Signaling Inhibition Attenuates Soleus Atrophy during Early Stages of Muscle Unloading.
Belova SP; Mochalova EP; Kostrominova TY; Shenkman BS; Nemirovskaya TL
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326654
[TBL] [Abstract][Full Text] [Related]
7. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
Castillero E; Alamdari N; Lecker SH; Hasselgren PO
Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
[TBL] [Abstract][Full Text] [Related]
8. The role of the recently discovered E3 ubiquitin ligase UBR5 in skeletal muscle mass regulation.
Dablainville V; Sanchez AMJ
J Physiol; 2019 Aug; 597(16):4133-4135. PubMed ID: 31264706
[No Abstract] [Full Text] [Related]
9. Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids.
Baehr LM; Furlow JD; Bodine SC
J Physiol; 2011 Oct; 589(Pt 19):4759-76. PubMed ID: 21807613
[TBL] [Abstract][Full Text] [Related]
10. The mERG1a channel modulates skeletal muscle MuRF1, but not MAFbx, expression.
Pond AL; Nedele C; Wang WH; Wang X; Walther C; Jaeger C; Bradley KS; Du H; Fujita N; Hockerman GH; Hannon KM
Muscle Nerve; 2014 Mar; 49(3):378-88. PubMed ID: 23761265
[TBL] [Abstract][Full Text] [Related]
11. Paradoxical effect of IKKβ inhibition on the expression of E3 ubiquitin ligases and unloading-induced skeletal muscle atrophy.
Belova SP; Shenkman BS; Kostrominova TY; Nemirovskaya TL
Physiol Rep; 2017 Aug; 5(16):. PubMed ID: 28839114
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of MuRF1 and MAFbx participates to muscle wasting upon gentamicin-induced acute kidney injury.
Aniort J; Polge C; Claustre A; Combaret L; Béchet D; Attaix D; Heng AE; Taillandier D
Int J Biochem Cell Biol; 2016 Oct; 79():505-516. PubMed ID: 27102410
[TBL] [Abstract][Full Text] [Related]
13. Deletion of atrophy enhancing genes fails to ameliorate the phenotype in a mouse model of spinal muscular atrophy.
Iyer CC; McGovern VL; Wise DO; Glass DJ; Burghes AH
Neuromuscul Disord; 2014 May; 24(5):436-44. PubMed ID: 24656734
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin Ligases at the Heart of Skeletal Muscle Atrophy Control.
Peris-Moreno D; Cussonneau L; Combaret L; Polge C; Taillandier D
Molecules; 2021 Jan; 26(2):. PubMed ID: 33466753
[TBL] [Abstract][Full Text] [Related]
15. The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy.
Lagirand-Cantaloube J; Offner N; Csibi A; Leibovitch MP; Batonnet-Pichon S; Tintignac LA; Segura CT; Leibovitch SA
EMBO J; 2008 Apr; 27(8):1266-76. PubMed ID: 18354498
[TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle hypertrophy and atrophy signaling pathways.
Glass DJ
Int J Biochem Cell Biol; 2005 Oct; 37(10):1974-84. PubMed ID: 16087388
[TBL] [Abstract][Full Text] [Related]
17. mTORC1 promotes denervation-induced muscle atrophy through a mechanism involving the activation of FoxO and E3 ubiquitin ligases.
Tang H; Inoki K; Lee M; Wright E; Khuong A; Khuong A; Sugiarto S; Garner M; Paik J; DePinho RA; Goldman D; Guan KL; Shrager JB
Sci Signal; 2014 Feb; 7(314):ra18. PubMed ID: 24570486
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms modulating muscle mass.
Glass DJ
Trends Mol Med; 2003 Aug; 9(8):344-50. PubMed ID: 12928036
[TBL] [Abstract][Full Text] [Related]
19. Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1.
Bodine SC; Baehr LM
Am J Physiol Endocrinol Metab; 2014 Sep; 307(6):E469-84. PubMed ID: 25096180
[TBL] [Abstract][Full Text] [Related]
20. A cell-autonomous role for the glucocorticoid receptor in skeletal muscle atrophy induced by systemic glucocorticoid exposure.
Watson ML; Baehr LM; Reichardt HM; Tuckermann JP; Bodine SC; Furlow JD
Am J Physiol Endocrinol Metab; 2012 May; 302(10):E1210-20. PubMed ID: 22354783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
